Even more concerning, the complex interaction between CSA enforcement, Food and Drug Administration approval and the patent system creates a pharmaceutical landscape that privileges high-cost synthetic compounds over naturally occurring
substances, while curtailing overall research. This system inhibits competition by granting monopolies to companies that develop proprietary therapeutics while discouraging subsequent research because of the challenges of gaining access to patented substances.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Community co-design to target diabetes and metabolic syndrome in Australian Indigenous peoples - Nature MedicineCommunity co-design to target diabetes and metabolic syndrome in Australian Indigenous peoples. Correspondence from Courtney Ryder and colleagues Flinders
Source: NatureMedicine - 🏆 451. / 53 Read more »
To Fight Superbugs, Farming and Medicine Must Change, U.N. SaysFarmers, drug makers and governments need to work together to curb the spread of drug-resistant bacteria and fungi, the United Nations says with what more drugs? According to maps produced by CDDEP, the main regions exhibiting antimicrobial resistance are developing nations with poor antimicrobial stewardship. None of the current drugs being developed can address this, hence we need to take all steps to improve prescribing habits This sounds like an oxymoron.
Source: WSJ - 🏆 98. / 63 Read more »
Superbugs Control Demands Change in Farming and Medicine, U.N. SaysDeaths from drug-resistant infections could rise from one million to 10 million annually by 2050 if antimicrobial resistance continues unchecked, the U.N. said Tuesday
Source: WSJhealth - 🏆 413. / 53 Read more »